Tobacco and alcohol use after head and neck cancer treatment: influence of the type of oncological treatment employed  by Pinto, Fábio Roberto et al.
ORIGINAL ARTICLE
SUMMARY
Objective: To assess the cigarette smoking and alcohol intake maintenance rate in pa-
tients treated for head and neck squamous cell carcinoma and to compare the observed 
outcome with the type of oncological treatment employed. Methods: One hundred and 
ten patients treated for high aero-digestive tract squamous cell carcinoma were included 
and divided into a surgical group, treated with a surgery, and a medical group, treated 
with chemotherapy and/or radiation. The patients were interviewed to determine wheth-
er or not they had persisted with the smoking and drinking behavior after treatment. 
The habit maintenance rate was compared with the treatment modality employed. The 
relationship between the oncological status of the patients and the cigarette smoking and 
alcohol intake rates found was also tested. Results: Among smokers, 35% maintained the 
habit after treatment. The medical group had a significantly higher percentage of patients 
maintaining smoking compared with the surgical group (58.3% vs 25.0%; p = 0.004). 
Among alcohol users, 16.6% kept drinking alcoholic beverages, with a percentage also 
shown higher for the medical group (23.8% vs 13,3%), but with no statistically significant 
difference. The oncological status of patients was not related to the maintenance of the 
habits studied. Conclusion: Smoking and alcoholism maintenance rates are high after 
head and neck squamous cell carcinoma is treated, especially if we consider smoking in 
patients treated with chemotherapy and/or radiation. A more effective multidisciplinary 
approach is required in order to obtain better rates of tobacco and alcohol quitting, espe-
cially in patients undergoing non-surgical treatments.
Keywords: Smoking; smoking cessation; ethanol; head and neck neoplasms; treatment 
outcome.
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INTRODUCTION
Smoking and alcoholism are well-known risk factors for 
head and neck squamous cell carcinoma (SCC) develop-
ment. Among the patients treated for this condition, about 
20% to 50% go on smoking after the treatment is comple-
te1,2. Some authors relate smoking and alcoholism after 
head and neck SCC treatment to lower scores in quality 
of life questionnaires, in addition to a lower overall survi-
val3-7. Aarstad et al.8 showed smoking levels are associated 
with a lower quality of life in patients successfully treated 
for head and neck SCC and, in those patients who have a 
drinking-to-cope behavior regarding their previous onco-
logical history, lower scores are also found in quality of life 
questionnaires.
According to some authors, continued smoking after 
treatment is highly related to alcoholism maintenance 
and both habits are related to lower body mass indexes in 
treated patients9. Continued use of tobacco increases re-
lapse and a second primary tumor risk10,11, reduces the ra-
diotherapy efficacy, exacerbates or extends complications 
secondary to head and neck cancer treatment, such as mu-
cositis and xerostomia, in addition to impaired pulmonary 
function and wound healing12. Heavy alcohol intake is also 
related to higher relapse indexes and to a second primary 
tumor13.
Recently, many patients carrying a head and neck 
SCC have undergone non-surgical treatments, particu-
larly concurrent radiotherapy and chemotherapy aim-
ing to preserve the organs affected by the primary tumor. 
Such a therapeutic option has been used more often for 
tumors located in the larynx and the throat, with a good 
oncological outcome, compared with conventional treat-
ment outcome, i.e., surgery and adjuvant radiotherapy. 
In a literature search, we found only a report where the 
authors studied the relationship between smoking cessa-
tion and the treatment modality employed14. In this study, 
Garces et al.14 demonstrated, in a group of patients treated 
for head and neck SCC found in several sites, that those 
treated with radiation alone had lower smoking cessation 
rates than those undergoing a surgery as a part of the early 
disease treatment. However, the authors do not discrimi-
nate how many patients underwent total laryngectomy in 
the surgical group and this reduces the outcome impact, 
though not making it invalid.
Thus, with a growing number of patients with head and 
neck SCC undergoing non-surgical treatment, we need 
to debate whether smoking and alcoholism maintenance 
rates in this group of patients are the same as in patients 
undergoing surgical treatment. If a really significant dif-
ference in the cessation of risk factors among available 
therapeutic modalities is proved, smoking and drinking 
cessation strategies should be adjusted depending on the 
oncological treatment employed. Thus, this study objec-
tive is to assess the smoking and alcoholism maintenance 
rate in patients treated for head and neck squamous cell 
carcinoma and determine whether the treatment modality 
has any impact on the observed outcome. We sought to 
determine whether maintaining the risk habits relates to 
the post-treatment oncological status.
METHODS
The protocol described below is a cross-sectional study 
approved by the Ethics and Research Committee in our 
institution and follows the Resolution 196/96 of the Na-
tional Health Board. Patients with squamous cell carcino-
ma in the high aero-digestive tract were included if they 
had undergone oncological treatment with an intention to 
cure purpose completed at least three months before their 
protocol inclusion. The patients were randomly selected 
in an outpatient routine service over two months as they 
came for scheduled follow-up visits. There was no prior 
review of the patient record which could compromise the 
case selection random character. The patients were inter-
viewed for maintenance of smoking and/or alcoholism 
habits after treatment. All patients were informed about 
the study objectives and gave a written informed consent 
before the interview. The interview was always conducted 
by the same health team professional attending the patient 
(F.R.P.). Over the interview, the patient was asked about 
his/her status regarding tobacco and ethylic alcohol habits 
and, in case the status was abstinence, for how long. Ha-
bit maintenance was defined as a setting in which the pa-
tient did not have a smoking and/or alcohol cessation or if 
he/she resumed these habits after an abstinence period. 
Habit cessation was considered when the patient had not 
been smoking or drinking alcoholic beverages for at least 
30 days from the interview date. This definition was ba-
sed on literature data15. It is important to stress that, in our 
practice, patients treated for high aero-digestive tract SCC 
are instructed about the relationship between smoking 
and/or alcoholism and their underlying disease and they 
are advised to give up these habits. As a rule, no drug in-
tervention is established to promote smoking and/or alco-
holism withdrawal in these patients.
The data regarding the treated disease and the patient 
habits previously to cancer diagnosis were collected from 
the patients’ medical records. From this information, all 
tumors were restaged according to the TNM classification 
by the Union Internationale Contre le Cancer – UICC, 6th 
edition – 2002. The oncological status was obtained from 
clinical assessment carried out during the visit preceding 
the interview. The following data was then registered in a 
standard card:
1. Patient’s age (at the diagnosis) and gender;
2. Primary tumor site and stage (clinical stages from I to 
IV);
3. Type of treatment (surgical or non-surgical);
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Mouth
2%28%
5%
32%
33%
Throat
Hypopharynx
Larynx
Unknown
Sites Mouth Throat Hypopharynx Larynx Unknown Total
no of cases 36 35 6 31 2 110
Figure 1 – Primary site at diagnosis. Percentage and 
absolute values.
Figure 2 – Staging at diagnosis. Percentage and absolute 
values.
Stage I7%
25%
25%
43% Stage II
Stage III
Stage IV
Staging Stage I Stage II Stage III Stage IV Total
no of cases 8 28 27 47 110
4. Smoking and alcohol use status before the treatment 
(YES or NO);
5. Smoking and alcohol use maintenance after the treat-
ment (YES or NO);
6. Oncological status: Alive and disease-free or alive and 
with the disease;
7. Time elapsed from the tumor diagnosis to the interview 
(stratified into four categories to allow for the analysis: 
3 to 12 months; 12 to 24 months; 24 to 36 months; > 36 
months)
EXCLUSION CRITERIA:
t Patients with nasopharynx or lip tumors, since other 
risk factors are involved at these sites;
t Patients undergoing palliative care.
The patients were allocated into two groups, with the 
surgical group being initially treated with surgery (re-
gardless any adjuvant treatment administered), and the 
medical group was initially treated with chemo and/or ra-
diotherapy (regardless any rescue performed in the follow-
up). The maintenance rate of studied habits was compared 
with the treatment modality employed (medical or surgi-
cal) through the chi-square test. The relationship between 
the oncological status of patients (alive and disease-free or 
alive and having the disease) and the smoking and alcohol 
use rates found was also tested. Statistical significance was 
considered when p < 0.05 (a error).
RESULTS
Over the two-month duration study, 110 patients that 
met the inclusion criteria and accepted to participate in 
the study were selected. Out of them, 94 were male and the 
mean age was 57.2 ± 10.2 years at the diagnosis. Most pa-
tients had high stage disease (stages III and IV), with the 
most frequent sites being mouth, throat and larynx (Figu-
res 1 and 2). At the diagnosis, 80 patients were smokers, 66 
were alcoholics, and 61 were both smokers and alcoholics. 
Most non-smoker or non-alcoholic patients at the diagno-
sis had at least one of these habits in their medical history. 
By comparing the treatment modality groups (surgical 
versus medical treatment), a sample homogeneity was ob-
served regarding the patient age, the tumor clinical stage, 
and the elapsed time between the tumor diagnosis and the 
interview (Table 1).
Analyzed Variable
Treatment
Significance
Surgical Medical
Age 57.3 ± 10.3 years 56.8 ± 10.1 years p = 0.801 (t Student)
Stage
    I 8.6% 3.4%
p = 0.156 
(chi-square)
    II 29.6% 13.8%
    III 24.7% 24.1%
    IV 37.1% 58.7%
Time to interview
    3 - 12 months 14.8 27.6%
p = 0.454 
(chi-square)
    12 - 24 months 29.6 20.7%
    24 - 36 months 27.2 24.1%
    > 36 months 28.4 27.6%
Table 1 – Comparison of groups according to the treatment modality concerning patients’ age, tumor clinical stage, elapsed 
time between tumor diagnosis and the interview
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Among the smokers, 35% maintained the habit after 
the treatment. By comparing the treatment modalities, 
there was a significantly higher percentage of patients 
maintaining smoking in the medical group over the sur-
gical group (58.3% vs. 25.0%; p = 0.004 – chi-square test; 
Table  2). Among the 56 smokers in the surgical group, 
12 (21.4%) underwent total laryngectomy and the re-
mainder underwent other kinds of surgery. After exclud-
ing the patients undergoing total laryngectomy because 
of the mechanical difficulty this operation brings on 
the smoking act and by comparing the post-treatment 
smoking rates in the surgical and medical groups, a sig-
nificantly higher percentage of patients maintaining ciga-
rette smoking was again found in the medically-treated 
group (58.3  vs.  27.3%; p  =  0.012 – chi-square test; Ta-
ble 3). Among the patients undergoing total laryngecto-
my, only two patients (16.6%) kept on smoking. Among 
the alcoholics, 16.6% continued drinking, a percentage 
that showed higher in the medical group than in the sur-
gical group, but with no statistically significant difference 
(23.8% vs, 13.3%; p = 0.307 – chi-square test; Table 4). 
The patients’ oncological status at the interview showed 
no relationship with the studied habit maintenance 
(Table 5).
DISCUSSION
Despite continuing government efforts to make the popu-
lation aware of tobacco harm, the smoking index in the 
world adult population is still high. In Brazil, one-fourth 
of the population is estimated to be nicotine dependent 
and subject to the morbidity and mortality caused by to-
bacco16. Alcoholic beverage consumption, a more socially 
accepted habit, is also high and begins increasingly earlier 
in many countries17,18. For a long time, these habits have 
been known to be related to the development of many di-
seases, particularly some malignant neoplasms. As for the 
high aero-digestive tract SCC, smoking and/or alcoholism 
history occurs in almost all diagnosed patients. Despi-
te they had been warned of the increased risk of relapse 
and other malignant tumor development related to conti-
nuing tobacco and alcohol use12,13, a significant percentage 
of patients treated for head and neck malignant tumors 
maintain or resume those habits after the treatment1,2. 
In addition, both persisting smoking and alcoholism are 
correlated with preexisting comorbidity worsening and a 
worse quality of life in this group of patients3-5,8. In recent 
years, with an increasing number of head and neck SCC 
cases primarily treated with chemotherapy and radiation, 
a seemingly increasing number of patients maintaining or 
resuming smoking and/or alcohol use has been observed 
in our outpatient practice, in spite of the medical, nursing 
and psychological team guidance. This clinical impression 
led us to carry the current study out.
The first remarkable result in our report regards the 
high index of patients maintaining smoking after the treat-
ment (35%). This outcome is comparable to data found 
in literature1,2,12. A smoking cessation rate significantly 
higher was observed among patients undergoing surgi-
cal treatment and this confirmed our initial clinical im-
pression. At first, the reasons why this group of patients 
has higher smoking cessation indexes may be related to a 
mechanical difficulty to smoking imposed by most head 
and neck SCC operations. However, after the patient’s re-
Table 2 – Total Smoking – medical group x surgical group. 
Absolute values and percentage
Smoking
Treatment
 TotalMedical Surgical
Yes 14 (58.3%) 14 (25%)  
No 10 (41.7%) 42 (75%)  
Total 24 (100%) 56 (100%) 80
p = 0.004 chi-square test
Table 3 – Smoking when total laryngectomies were excluded 
– medical group  x  surgical group. Absolute values and 
percentage
Smoking
Treatment
TotalMedical Surgical
Yes 14 (58.3%) 12 (27.3%)  
No 10 (41.7%) 32 (72.7%)  
Total 24 (100%) 44 (100%) 68
p = 0.012 chi-square test
Table 4 – Post-treatment alcoholism - medical group x 
surgical group. Absolute values and percentage
Alcoholism
Treatment
TotalMedical Surgical
Yes 5 (23.8%) 6 (13.3%)  
No 16 (76.2%) 39 (86.7%)  
Total 21 (100%) 45 (100%) 66
p = 0.307 – Fisher’s exact test
Tabela 5 – Oncological status x smoking and alcoholism 
maintenance or not
Habit Status
Total
Smoking*
Alive and 
disease-free
Alive and with 
the disease
Yes 24 (34,8%) 4 (36,4%)
No 45 (65,2%) 7 (63,6%)
Total 69 (100%) 11 (100%) 80
Alcoholism**
Yes 8 (14%) 3 (33,3%)  
No 49 (86%) 6 (66,7%)  
Total 57 (100%) 9 (100%) 66 
*p = 0.165 – Fisher’s exact test ** p = 1.000 – Fisher’s exact test
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covery and speech rehabilitation, only total laryngectomy 
partially prevents smoking resumption. Actually, Chan et 
al.15 showed the tumor site was the only statistically signifi-
cant finding associated with smoking cessation after the 
diagnosis: 64.2% of patients with hypopharynx and larynx 
SCC quit smoking, whereas only 35.8% of patients with 
throat or oral cavity SCC did it (p = 0.01). Thus, we ex-
cluded from our analysis the patients undergoing total lar-
yngectomy and compared the treatment groups again: one 
more time, there was a significantly higher smoking cessa-
tion in the surgical group. This outcome makes us consider 
other factors, in addition to the mechanical restriction im-
posed by the surgery performed, contribute to the higher 
smoking cessation index in surgically treated patients. The 
psychological impact of surgical treatment, in addition to 
the functional and cosmetic changes imposed by an onco-
logical surgery, might lead to the higher smoking cessation 
rate observed in the current study.
Regarding alcoholism, we observed the maintenance 
or resumption rate was lower than for smoking, thus su-
ggesting chemical and/or psychological dependence can 
be lower than that for tobacco. A comparison between 
the treatment groups showed similar results to those ob-
served for smoking, i.e., a higher alcoholism cessation 
index for patients in the surgical group, mas there was no 
statistical significance. No kind of surgery was required 
to be excluded from the analysis, since all interviewed 
patients had reached an appropriate rehabilitation of 
their swallowing ability postoperatively. Despite all ope-
rated patients had an appropriate swallowing when they 
were interviewed, many of them remained several weeks 
on a postoperative diet delivered by an enteral tube alo-
ne. Except for the total laryngectomy cases, most ope-
rated patients undergoing a transient tracheostomy and 
naso-enteral feeding tube placement had their respira-
tory function restored ahead of the swallowing function, 
with the tracheostomy being removed before the enteral 
tube. Therefore, these patients could resume smoking 
earlier than they used alcohol again. This rehabilitation 
time difference for respiratory and swallowing functions 
cooperated for the higher alcoholism cessation index in 
surgically treated patients.
Despite several authors have reported an increased 
risk of disease relapse and new primary tumor develop-
ment in patients maintaining or resuming smoking and/
or alcoholism after head and neck SCC treatment10-12,19-21, 
in the current study, the oncological status of patients 
did not show any relationship with maintenance or re-
sumption of these habits. Another important finding that 
deserves to be pointed out is the observed results were 
not influenced by occasional confounders, since the tre-
atment modality groups are homogenous for patient age, 
clinical stage and time elapsed between the tumor diag-
nosis and the interview.
CONCLUSION
In short, the current study results demonstrated that 
smoking and alcoholism maintenance and/or recurrence 
rates are high in patients treated for head and neck SCC in 
Brazil, meaning only patient advice is not enough as a stra-
tegy leading to this habit cessation. It is crucial head and 
neck surgeons, as well as other related specialists unders-
tand nicotine and alcohol dependence is related to com-
plex neurological, psychic and behavioral mechanisms 
described in detail in literature16,22,23 and that success in in-
terruption and abstinence of these habits does not depend 
solely on the patient comprehension and will. More effi-
cacious measures aiming at tobacco and alcohol cessation 
and non-resumption are required, mainly for the group of 
patients undergoing non-surgical treatment.
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